IMMUNIC, INC. - IMUX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | OrbiMed Advisors LLC | 5.3% | 756,860 | View |
| Aug 14, 2026 | SCHEDULE 13G | OrbiMed Genesis GP LLC | 5.3% | 756,860 | View |
| Aug 14, 2026 | SCHEDULE 13G | OrbiMed Capital LLC | 2.8% | 388,540 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 7.47% | 1,079,843 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 7.47% | 1,079,843 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Daniel Mack | 7.47% | 1,079,843 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 9.9% | 1,511,821 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 9.9% | 1,511,821 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Robert Egen Atkinson | 9.9% | 1,511,821 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Michael Kramarz | 9.9% | 1,511,821 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Master Fund, L.P. | 4.9% | 679,200 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital, LLC | 4.9% | 679,200 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Group, LLC | 4.9% | 679,200 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus Capital Management, L.P. | 4.9% | 679,200 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Soleus GP, LLC | 4.9% | 679,200 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Guy Levy | 4.9% | 679,200 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Integrated Core Strategies (US) LLC | 6.9% | 960,816 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Millennium Management LLC | 7.0% | 969,547 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Millennium Group Management LLC | 7.0% | 969,547 | View |
| Aug 06, 2026 | SCHEDULE 13G/A | Israel A. Englander | 7.0% | 969,547 | View |
| Aug 04, 2026 | SCHEDULE 13G | Laurion Capital Management LP | 6.06% | 839,526 | View |
| Aug 04, 2026 | SCHEDULE 13G | Benjamin Alexander Smith | 6.06% | 839,526 | View |
| Aug 04, 2026 | SCHEDULE 13G | Janaka Sheehan Maduraperuma | 6.06% | 839,526 | View |
| Jul 16, 2026 | SCHEDULE 13G/A | Aberdeen Group plc | 6.05% | 824,393 | View |
| Jul 16, 2026 | SCHEDULE 13G/A | abrdn Inc. | 6.05% | 824,393 | View |
| May 15, 2026 | SCHEDULE 13G/A | Alyeska Investment Group, L.P. | 4.85% | 6,332,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Alyeska Fund GP, LLC | 4.85% | 6,332,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Anand Parekh | 4.85% | 6,332,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | 683 CAPITAL MANAGEMENT, LLC | 3.4% | 474,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | 683 CAPITAL PARTNERS, LP | 3.4% | 474,200 | View |
| May 15, 2026 | SCHEDULE 13G/A | Zweiman Ari | 3.4% | 474,200 | View |
| May 06, 2026 | SCHEDULE 13G | Integrated Core Strategies (US) LLC | 5.4% | 743,281 | View |
| May 06, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.7% | 793,621 | View |
| May 06, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.7% | 793,621 | View |
| May 06, 2026 | SCHEDULE 13G | Israel A. Englander | 5.7% | 793,621 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Partners Management LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Partners Management (GP) LLC | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Capital Partners Fund (GP) LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Capital Partners (GP) LLC | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Avidity Private Master Fund I LP | 9.9% | 13,958,410 | View |
| Apr 17, 2026 | SCHEDULE 13G | Michael Gregory | 9.9% | 13,958,410 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.